VerityRank
BrandChina

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd is a China company whose shares trade on SSE under the ticker 601607.SS. Its market capitalisation stands near $9.26 billion as of October 2026. Monthly closes and the full price history are shown below. Figures come from exchange data and are cross-checked against company filings.
Read More ▼
China / 100
Listed onSSE601607.SS
Last Updated: October 2026·By VerityRank Research Team·Methodology

Listed market data

601607.SS · SSE · weeklyHistory →
Market cap
$9.3B
Share price
≈ CNY 1671.00
1Y change
-7.0%
3Y change
-8.8%
Since first close
+455.5%

from 1994-03

· updated 2026-10-20

Financial history

Full market history
CNY 0$0CNY 6$3.8BCNY 13$7.5BCNY 19$11.3BCNY 25$15.0B2024-112025-012025-032025-052025-072025-092025-112026-012026-032026-052026-072026-09
MonthCloseMarket cap
  • 2026-10CNY 16.45≈ $9.3B
  • 2026-09CNY 16.22≈ $9.1B
  • 2026-08CNY 16.25≈ $9.1B
  • 2026-07CNY 16.86≈ $9.5B
  • 2026-06CNY 15.40≈ $8.7B
  • 2026-05CNY 16.48≈ $9.3B
  • 2026-04CNY 17.09≈ $9.6B
  • 2026-03CNY 17.05≈ $9.6B
  • 2026-02CNY 17.20≈ $9.7B
  • 2026-01CNY 17.30≈ $9.7B
  • 2025-12CNY 17.86≈ $10.1B
  • 2025-11CNY 17.81≈ $10.0B
  • 2025-10CNY 17.94≈ $10.1B
  • 2025-09CNY 17.95≈ $10.1B
  • 2025-08CNY 18.67≈ $10.5B
  • 2025-07CNY 19.04≈ $10.7B
  • 2025-06CNY 17.88≈ $10.1B
  • 2025-05CNY 18.42≈ $10.4B
  • 2025-04CNY 17.96≈ $10.1B
  • 2025-03CNY 18.55≈ $10.4B
  • 2025-02CNY 19.20≈ $10.8B
  • 2025-01CNY 20.15≈ $11.3B
  • 2024-12CNY 21.00≈ $11.8B
  • 2024-11CNY 21.75≈ $12.2B
Monthly closes · 2024-11 – 2026-10 · full history in market history

Quick Facts

Headquarters

China

Market cap

$9.3B

Listing

SSE: 601607.SS

Categories
Life & Services

Related

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: SSE: 601607.SS